SLC5A2 and type 2 diabetes mellitus: Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) constitute a class of antidiabetic agents, used to reduce blood glucose by decreasing glucose reabsorption via inhibition of glucose cotransporter 2 in the kidney in type 2 diabetes patients.